Patients and Caregivers

Gynecologic and breast cancers will affect approximately 250,000 women each year.

Fujirebio Diagnostics, Inc. is dedicated to providing women and their families with resources and education about cancer and the role of tumor markers in the management of disease. We hope that you find the information and links useful in your search to gather additional information.

If you would like to receive additional information please contact us at customerservice@fdi.com.


Fujirebio Diagnostics
CA 125II™ is the
most widely used biomarker worldwide
for ovarian cancer.